Multiple Sclerosis Treatment Becomes Canada’s First MS Stem Cell Clinical Trial.

The University of Ottawa trial infuses MSCs to reduce inflammation in the central nervous systems of MS patients.

The Multiple Sclerosis Society of Canada has funded Canada’s first stem cell clinical trial to treat multiple sclerosis, conducted by researchers at the University of Ottawa. The trial, called MESCAMS [Mesenchymal Stem Cell Therapy for Canadian MS patients], will comprise MSC infusions to the central nervous system to utilize their ability to regulate autoimmune attacks and reduce inflammation in 40 MS patients. Continue reading

Multiple Sclerosis Trial Exhibits Positive Results of Stem Cell Therapy.

A five year phase II clinical trial has shown initial success in treating multiple sclerosis.

In a recent update of an ongoing five year clinical trial conducted by the Chicago Blood Cancer Institute, patients with relapsing-remitting multiple sclerosis have experienced suppression of disease-related inflammation as a result of hematopoietic stem cell transplantations.  The stem cells have the ability to regulate the autoimmune attack on the central nervous system, and have provided 82.8% of the patients with two years thus far of event-free disease remission. Continue reading

Lupus Therapy Incorporates Mesenchymal Stem Cells

Beijing researchers are capitalizing on the abilities of mesenchymal stem cells to reduce inflammation and promote cell growth to combat systemic lupus erythematosus.

In a recent clinical study conducted in Beijing, researchers are testing a treatment for patients suffering from systemic lupus erythematosus by administering autologous [the patient’s own] mesenchymal stem cells.  The researchers aim to capitalize on the unique abilities of MSCs to not only differentiate into a multitude of different cell types, but to reduce the autoimmune attack in patients affected by lupus as well. Continue reading

New York Times: The Eruption of Stem Cell Therapies.

Mr. Edgar Irastorza is one of thousands of people already benefiting from the progression of stem cell based therapies.

As reported on the front page of the New York Times Science section, clinical applications of stem cell based therapies are accelerating at a rate that will revolutionize the medical field in a matter of years.  In the United States alone, there are currently over 4000 therapies in clinical trials for the treatment of heart disease, blindness, spinal cord injuries, diabetes, H.I.V., and other diseases, injuries, and traumas. Continue reading

Osteoarthritis Stem Cell Treatment in Clinical Trial

The transplantation of stem cells into areas affected by osteoarthritis allow lost cartilage tissue to regenerate.

In recent clinical trials, researchers at the National University of Ireland Galway have successfully utilized adult stem cells to treat patients with osteoarthritis.  The treatment involves recovering the patients’ own [autologous] stem cells and then injecting the stem cells into cartilage to stimulate the regeneration of lost tissue. Continue reading

Spinal Cord Treatment Utilizes Stem Cells.

Researchers at the University of California, San Diego have begun clinical trials for a spinal cord treatment that utilizes stem cells.

Researchers at the University of California, San Diego are set to begin clinical trials to test the safety and effectiveness of a neural stem cell transplant designed to treat spinal cord injuries.  In an animal model, the stem cells were able to regenerate the nerves across the site of injury, resulting in the restoration of mobility in the legs. Continue reading

Plantar Fasciitis Alleviated by Stem Cell Therapy

Stem cell therapy offers faster, longer lasting pain relief than traditional treatments for plantar fasciitis.

Doctors from pain clinics across the country, such as the Arizona Pain Stem Cell Institute, are now offering stem cell therapies to patients suffering from plantar fasciitis.  The new treatment involves injections of bone-derived stem cells to reduce inflammation and regenerate damaged tissue in the plantar fascia. Continue reading

Thalassemia Major Cured Utilizing Stem Cells in Umbilical Cord Blood

Stem Cell Transplantation from cord blood successfully cured patients with Thalassemia.

Scientists from the Mediterranean Institute of Haematology have developed a treatment that utilizes stem cells from umbilical cord blood to cure children of a life-threatening blood disorder called Thalassemia Major.  The procedure involves the transplantation of stem cells from cord blood into the Thalassemia patient.  Recent applications [in India] of this breakthrough procedure have resulted in several children being cured of the disease. Continue reading

Ninth Annual New York Stem Cell Summit to Convene February 18th

The leaders of the Stem Cell Industry will address the future of Regenerative Medicine

The Ninth Annual Stem Cell Summit will take place on February 18th in New York City.  The summit will feature presentations from the stem cell industry’s premier researchers, executives, and investors to address recent advances and this year’s expectations of the Stem Cell / Regenerative Medical industry. Continue reading

Stem Cell Clinical Trials to Treat Genetic Disorders Announced

DNA strand

Gene therapies utilizing stem cells are being developed that may lead to a cure for several genetic diseases. Currently, two clinical trials were announced to treat Cerebral Adrenoleukodystrophy (CCALD) and betathalassemia/sickle cell disease.

Continue reading